Clinical Trial Update: Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating RX-10045 for dry eye syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• RX-10045

Snippet

Sponsor: Resolvyx Pharmaceuticals, Inc | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED